However, recent remedies such as glucagon-like peptide −1 (GLP-I) analogs and selective glucose transporters-2 (SGLT-2) inhibitors should be considered in all subjects with diabetes who lack contraindications (DiBenedetti et al., 2019). The gene discussed is GCG; the disease is diabetes mellitus.